What if surgical robots are cleared to operate autonomously?
Approval of a supervised-autonomous surgical robot is a high-value robotics-productivity event — long Nvidia/edge-AI and surgical-robotics names (ISRG), with medical-malpractice repricing as a second-order theme; light displacement risk since it augments scarce surgeons. Rhymes with the May-2023 Nvidia capex-wave. The risk-on tilt is appropriate; this is capability expansion, not labor destruction.
Every number ships with its receipt — the odds, the range, the precedents, and a public grade at Reality Check. The statistical machinery that produces it is proprietary.
The butterfly cascade
How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.
Resolution timeline — how this probability is moving
Our model's odds (electric blue) over time vs the market's (Polymarket, amber), from the past toward the 1–3 years horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. Loading the probability audit trail…
What it would mean
If this plays out, it is a risk-on shock. Regulators approve first supervised-autonomous surgical robot, reordering hospital staffing and medical-malpractice insurance pricing. The trigger decomposes into signed root‑shocks — Job displacement ▲ · Robotics productivity ▲ — which propagate through our causal graph to the markets below.